We are excited to announce that Meticuly has been selected to exhibit at TechCrunch Disrupt 2024, held from October 28th - 30th at the Moscone Center in San Francisco, securing a spot in Booth K14 on October 30th. Known for showcasing industry-defining startups and cutting-edge technology, this year's event is set to inspire. We invite you to visit our booth and connect with our leadership team to explore how Meticuly is driving innovation in patient-specific 3D-printed implants and revolutionizing personalized healthcare solutions.
Introducing Meticuly’s proprietary Generative AI
Combining expertise in both medical and technology fields, Meticuly is proud to showcase proprietary Generative AI. Developed and trained in-house with over 500,000 datasets, the machine learning model automates complex processes in medical imaging and 3D bone reconstruction, including digital twin. This drastically reduces design lead times from days to minutes while maintaining precision in personalized implant 3D printing and flawless pre-operative planning.
As a result, the proprietary AI-enabled workflow can significantly enhance the ability to manage more patient cases than ever, in order to support an increasing demand from company's entry into the U.S. market in 2024 with 2 product lines, Patient-Specific Cranial Mesh, with 510(k) clearance in 2022, and Patient-Specific Maxillofacial + Orbital Mesh, 510(k) cleared in 2024. As Meticuly continues to scale and introduce more product lines, this innovation will ensure seamless expansion while maintaining the precision and customization that are core to its personalized healthcare solutions.
Led by CEO, Dr. Boonrat Lohwongwatana
Join us at Booth K14 on October 30th or connect with us at any day during the event. Dr. Boonrat Lohwongwatana - CEO, Douglas Abrams - CFO, and Dr. Techawit Hirisatja - Director of Customer Success, will be available on-site to discuss any technology, vision, and partnership opportunities. This is an exciting milestone for Meticuly, as the leadership team is eager to engage with investors, healthcare professionals, and industry leaders to drive the next generation of personalized implants.
About TechCrunch Disrupt
TechCrunch Disrupt is the premier event for tech startups and innovators, bringing together entrepreneurs, investors, and tech enthusiasts from across the globe. The main event, Startup Battlefield has helped launch notable companies like Dropbox, Mint, and Yammer, setting the stage for emerging technologies to make their mark. This year’s TechCrunch Disrupt 2024 will be held from October 28th - October 30th at the Moscone Center in San Francisco.
About Meticuly
Meticuly is a medical device company specializing in AI-driven, 3D-printed patient-specific titanium implants for cranial, maxillofacial, and orthopedic surgeries. Founded in 2017, the company leverages AI and precision manufacturing to create patient-specific implants, achieving one of the fastest lead times in the industry. Meticuly's quality management system complies with ISO 13485 and MDSAP standards. Company has served in Southeast Asia, the Middle East, and the UK. Meticuly expanded to the U.S. with two 510(k) clearances in 2022 and 2024. Recognized as the 2024 WIPO Global Award winner.
To schedule a meeting, drop us a message at contact.us@meticuly.com